pulmonary sarcoidosis
pulmonary sarcoidosis
Explore linked clinical trials. Standard reference: MONDO:000170816 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of Tulisokibart (MK-7240) in Participants With Pulmonary Sarcoidosis (MK-7240-016) | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Not yet recruiting | Phase 2 | 2026-10-09 | NCT07867938 | |
| Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Recruiting | Phase 2 | 2026-10-08 | NCT06205121 | |
| Role of Genetic Factors in the Development of Lung Disease | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Fibrosis, Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, Hypersensitivity, Immediate, Infant, Newborn, Diseases, Malformations of Cortical Development, Group I, Neoplasms, Multiple Primary, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, Subcutaneous Emphysema, alpha 1-antitrypsin deficiency, asthma, bronchial disorder, central nervous system malformation, cerebral cortical dysplasia, cystic fibrosis, hamartoma, hereditary disease, hereditary neoplastic syndrome, immune system disorder, inherited neurodegenerative disorder, interstitial lung disease, liver disorder, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, obstructive lung disease, pancreas disorder, pulmonary emphysema, pulmonary fibrosis, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis, tuberous sclerosis | Recruiting | Not stated | 2026-10-08 | NCT00001532 | |
| Study of Multiple-Ascending-Dose Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-02 | NCT05890729 | |
| Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Recruiting | Phase 4 | 2026-09-17 | NCT05841758 | |
| An Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Not yet recruiting | Phase 2 | 2026-08-31 | NCT07680166 | |
| An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Active, not recruiting | Phase 2 | 2026-08-21 | NCT06169397 | |
| Diagnostic Value of EBUS-Guided Transbronchial Mediastinal Cryobiopsy Versus Conventional Bronchoscopic Approaches for Stage I/II Sarcoidosis | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Active, not recruiting | Not applicable | 2026-08-06 | NCT07246876 | |
| Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Not yet recruiting | Phase 2 / Phase 3 | 2026-06-25 | NCT07668895 | |
| A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, Usual Interstitial Pneumonia, cardiovascular disorder, hypertensive disorder, idiopathic pulmonary fibrosis, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary fibrosis, pulmonary hypertension, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis, vascular disorder | Not yet recruiting | Not stated | 2026-05-29 | NCT07613216 | |
| Feasibility of Semaglutide in Advanced Lung Disease | Body Weight, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, chronic obstructive pulmonary disease, hypertensive disorder, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, nutritional disorder, obesity disorder, obstructive lung disease, overnutrition, pulmonary hypertension, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis, vascular disorder | Recruiting | Phase 1 / Phase 2 | 2026-04-21 | NCT05746039 | |
| the PHENOSAR Trial: Use of Antibiotics in Treatment of Sarcoidosis | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Active, not recruiting | Not applicable | 2026-02-12 | NCT05291468 | |
| Risk Indicators of Sarcoidosis Evolution-Unified Protocol | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Recruiting | Not stated | 2026-01-08 | NCT05567133 | |
| Comparative Diagnostic Yield of Endobronchial Cryo Biopsy vs Forceps Biopsy in Patients With Suspected Sarcoidosis | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Recruiting | Not applicable | 2025-03-03 | NCT06853834 | |
| Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, cardiovascular disorder, connective tissue disorder, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, musculoskeletal system disorder, pulmonary sarcoidosis, respiratory system disorder, rheumatic disorder, rheumatoid arthritis, sarcoidosis, vascular disorder, vasculitis | Enrolling by invitation | Not applicable | 2024-11-25 | NCT03755245 | |
| RCT of Nintedanib in Fibrotic Sarcoidosis | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis | Recruiting | Phase 4 | 2024-10-23 | NCT06479603 |